Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

321
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
321
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

310
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
310
Data: Types and Distribution01:19

Data: Types and Distribution

2.2K
In biostatistics, data are the observations collected for analysis. There are two main types: parametric and non-parametric. Parametric data, which include continuous (e.g., weight) and discrete numerical data (e.g., number of tablets), assume a particular distribution pattern, often the normal distribution. Non-parametric data do not adhere to a specific distribution and typically comprise nominal (e.g., gender) and ordinal categorical data (e.g., pain scale ratings).
Distributions in...
2.2K
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

571
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
571
Weighted Mean00:57

Weighted Mean

7.3K
While taking the arithmetic, geometric, or harmonic mean of a sample data set, equal importance is assigned to all the data points. However, all the values may not always be equally important in some data sets. An intrinsic bias might make it more important to give more weightage to specific values over others.
For example, consider the number of goals scored in the matches of a tournament. While computing the average number of goals scored in the tournament, it may be more important to...
7.3K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

650
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
650

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Days at Home Up to 30 Days After Robotic Versus Laparoscopic Colorectal Surgery.

Diseases of the colon and rectum·2025
Same author

The value of routine histopathological examination after haemorrhoidectomy in patients at low and high risk of anal squamous intraepithelial lesions and cancer.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2025
Same author

Examining Different Methods to Assess Busulfan Exposure in Pediatric Hematopoietic Stem Cell Transplant Recipients.

Therapeutic drug monitoring·2025
Same author

Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses.

Frontiers in pharmacology·2025
Same author

Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study.

Thrombosis and haemostasis·2024
Same author

A physiological approach to renal clearance: From premature neonates to adults.

British journal of clinical pharmacology·2023

Related Experiment Video

Updated: Mar 22, 2026

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

3.0K

A Bayesian Modelling Approach with Balancing Informative Prior for Analysing Imbalanced Data.

Kerenaftali Klein1, Stefanie Hennig2, Sanjoy Ketan Paul1

  • 1Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, Australia.

Plos One
|April 13, 2016
PubMed
Summary
This summary is machine-generated.

This study introduces a Bayesian modeling approach with a balancing informative prior to minimize prediction bias in imbalanced datasets. The new method improves prediction accuracy for smaller data subsets, enhancing model robustness.

More Related Videos

Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects
08:13

Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects

Published on: May 10, 2019

6.9K

Related Experiment Videos

Last Updated: Mar 22, 2026

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

3.0K
Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects
08:13

Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects

Published on: May 10, 2019

6.9K

Area of Science:

  • Statistics
  • Computational Biology
  • Pharmacometrics

Background:

  • Imbalanced datasets pose challenges in predictive modeling, potentially biasing results towards majority subpopulations.
  • Accurate prediction for underrepresented groups is crucial in various scientific applications, including clinical dose optimization.

Purpose of the Study:

  • To develop a Bayesian modeling approach incorporating a balancing informative prior to mitigate the impact of data imbalance.
  • To enhance the prediction accuracy and robustness of models dealing with datasets where certain subpopulations are scarcely sampled.

Main Methods:

  • Development of a Bayesian modeling framework utilizing a balancing informative prior to re-weight data in favor of smaller subsets.
  • Assessment of the method's performance using simulated datasets, evaluating bias and precision of model parameter estimates.
  • Application of the approach to a real-world example of predicting optimal tobramycin dosage across different age groups.

Main Results:

  • The balancing informative prior approach demonstrated reduced bias compared to conventional methods that do not account for data imbalance.
  • Superior precision estimates were observed with the proposed Bayesian method.
  • Predictions for optimal tobramycin dosage aligned well with existing literature, validating the approach's practical utility.

Conclusions:

  • The proposed Bayesian balancing informative prior approach effectively addresses data imbalance by appropriately weighting smaller data subsets.
  • This method offers a robust strategy for generating reliable prediction models, particularly in scenarios with significant subpopulation disparities.
  • The approach shows significant potential for improving predictive accuracy in fields such as pharmacometrics and personalized medicine.